Workday shares fell sharply after the company’s updated subscription revenue forecast failed to impress investors. The software maker’s guidance showed minimal improvement despite recent AI acquisitions and product launches.
The AI boom isn’t just about compute power anymore. Networking has become the hidden bottleneck that’s limiting AI performance at scale. Here’s why traditional networks are failing and what’s being done to fix it.
A now-deleted ESRB rating reveals Death Stranding 2: On the Beach has been rated for Windows PC. This suggests the critically acclaimed Kojima Productions sequel will follow Sony’s typical PC release pattern of 1-2 years after PlayStation launch.
Workday’s revenue grew 12.6% to $2.4 billion last quarter, but customer headcount stagnation threatens its per-seat pricing model. The company is now aggressively cross-selling to existing customers to maintain growth.
Michael Burry has disclosed he holds put options against both Nvidia and Palantir, calling Nvidia’s recent memo “disingenuous” and full of “straw man” arguments. The investor, famous for predicting the 2008 housing crash, says AI companies are dangerously extending chip depreciation timelines. His b
CRISPR technology has been used to modify everything from bacteria to human embryos since 2012. While designer babies face ethical guardrails, gene-edited crops are entering a regulatory “Wild West” with minimal oversight.
Dell reported weaker-than-expected quarterly revenue despite booming AI server sales. The company’s PC business declined 7% annually, highlighting the challenges facing traditional hardware segments even as AI infrastructure demand surges.
Altice USA has filed a federal lawsuit accusing its creditors of illegally colluding to force the company into bankruptcy. The case represents a major escalation in distressed debt litigation tactics and could redefine how competition law applies to debt restructurings.
A new AI system called CytoDiffusion can analyze blood cell shapes with higher accuracy than human experts. The tool detected leukemia-related abnormalities with remarkable sensitivity and even knew when it was uncertain.
The controversial AI-powered teddy bear that was pulled from the market for giving dangerous advice to children is already back. FoloToy claims it spent a week reinforcing safety modules, but experts are skeptical about whether such quick fixes can address fundamental AI safety issues.
